Biognosys, a frontrunner in mass spectrometry-based proteomics, and Alamar Biosciences, Inc., a pioneer in precision proteomics for early disease detection, have forged a strategic alliance to prop
PolTREG SA, a Warsaw Stock Exchange listed pioneering clinical-stage biotechnology firm specializing in cellular therapies targeting autoimmune ailments, has disclosed pivotal findings in Internati
Yatharth Hospital stock will list on the exchanges on Monday. The IPO was oversubscribed by 37 times with strongest response in Qualified Institutional segment with 86 times oversubscription.